(Q77568881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Andrzej Wierzbicki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Irena Kiszka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Hiroshi Kaneko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Dariusz Kmieciak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Jaroslaw Gzyl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Yutaro Kaneko

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Danuta Kozbor

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

number of pages

13

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

9-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

1295-1307

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

Human immunodeficiency virus type 1 infection, mucosal immunity, and pathogenesis and extramural research programs at the National Institutes of Health

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Direct ex vivo simian immunodeficiency virus (SIV)-specific cytotoxic activity detected from small intestine intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Oral immunization of humans with dehydrated liposomes containing Streptococcus mutans glucosyltransferase induces salivary immunoglobulin A2 antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Targeting and controlled release of antigens for the effective induction of secretory antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Mushrooms, tumors, and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Clinical efficacy of lentinan on neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Systemic immunological effects of cytokine genes injected into skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Improved cationic lipid formulations for in vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900480-7

7 January 2021

10.1016/S0264-410X(01)00480-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11818148%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference